Liquidity
Strong1,020.82
How the figure is assessed
Current assets divided by current liabilities. Below 1.0 is weak, 1.0–1.5 needs attention and 1.5 or more is strong.
Org. no. 916 266 081 · Private limited company (AS) · Active · Uraveien 32, 8802, SANDNESSJØEN · ALSTAHAUG · 72.100 – Research and experimental development on natural sciences and engineering
SALMO PHARMA AS is a private limited company (as) registered in SANDNESSJØEN since 2015. The organisation number is 916 266 081. The latest submitted annual accounts are for 2025.
Source: The Brønnøysund Register Centre · Last updated 22 November 2026 at 08:55
Quick overview
Based on the latest submitted annual accounts (2025) and registry data.
1,020.82
Current assets divided by current liabilities. Below 1.0 is weak, 1.0–1.5 needs attention and 1.5 or more is strong.
–
Operating profit divided by operating revenue. Below 0% is weak, 0–10% needs attention and 10% or more is strong.
99.9 %
Equity divided by assets. Below 10% is weak, 10–30% needs attention and 30% or more is strong.
Calculated by us
Based on status, solvency, liquidity, profitability, trend and how recent the accounts are. Public register data only.
This is an indicative assessment, not a credit rating. It does not replace your own due diligence before entering into an agreement.
Proffi+
Calculating …
Indicative model estimate based on public accounting figures and typical industry multiples. Not an appraisal, a valuation or investment advice.
Development
Revenue and profit
RevenueResult
Development
Solvency and profitability (%)
SolidityProfitability
Registry data
Addresses
Not registered
Industry
Research and experimental development on natural sciences and engineering(main industry)
N Professional, scientific and technical activities › 72 Scientific research and development › 72.1 Research and experimental development on natural sciences and engineering › 72.10 Research and experimental development on natural sciences and engineering
See the industry: largest companies and key figures →Omfatter: Forskning og eksperimentell utvikling innenfor naturvitenskap og teknikk; forskning og utvikling innenfor naturvitenskap, forskning og utvikling innenfor teknikk og teknologi, forskning og utvikling innenfor medisin, helse og veterinærvitenskap, forskning og utvikling innenfor bioteknologi, forskning og utvikling innenfor jordbruk, skogbruk og fiske, tverrfaglig forskning og utvikling, hovedsakelig innenfor naturvitenskap og teknikk. Omfatter også: DNA-sekvensering når formålet er generell forskning på biologiske prosesser. Ekskluderer: DNA-sekvensering for å utelukke eller kurere en spesifikk sykdom grupperes under 86.91 Medisinske laboratorietjenester og bildediagnostikk.
Institutional sector code: Private aksjeselskaper mv. (2100)
Utføre forsøk og utviklingsarbeid innen akvakultur for næringsliv, offentlig organ og andre. Medvirke til undervisning/opplæring, rådgivnings- og utviklingsarbeid innen akvakultur. Gjennom samarbeid med brukere, formidle informasjon om FoU-resultat, og bidra til at disse blir tatt i bruk. Drive oppdrett av laks, ørret og eventuelt andra arter. Investeringer i og drift og utleie av eiendom og driftsmidler, samt investeringer i aksjer og andeler.
Registry status
Experiences
Loading reviews …
You must sign in with a verified email to write a review.
Financial overview
Fiscal year 2025 · Amounts in NOK
Data basis
3 stored years
1,020.82
Current assets divided by current liabilities. Below 1.0 is weak, 1.0–1.5 needs attention and 1.5 or more is strong.
–
Operating profit divided by operating revenue. Below 0% is weak, 0–10% needs attention and 10% or more is strong.
99.9 %
Equity divided by assets. Below 10% is weak, 10–30% needs attention and 30% or more is strong.
Only reported amounts from the Register of Company Accounts
| Accounting item | 2025 | 2024 | 2023 | Development |
|---|---|---|---|---|
| Operating revenue | – | 10,612,217 | 41,024 | |
| Operating profit | -3,166,945 | 7,346,117 | -3,776,910 | |
| Profit before tax | -2,699,598 | 8,700,082 | -2,579,067 | |
| Net result | -2,101,320 | 7,076,990 | -1,265,325 | |
| Total assets | 10,840,694 | 13,461,116 | 36,482,933 | |
| Equity | 10,830,671 | 12,931,990 | 25,855,000 | |
| Liabilities | 10,024 | 529,126 | 10,627,933 |
Graphical analysis
Amounts in NOK
Calculated by us, in percent
Balance sheet in NOK
Register of Company Accounts
Period 2025-01-01 to 2025-12-31. Currency NOK. Audited annual accounts.
| Total operating expenses | 3,166,945 NOK |
|---|---|
| Operating profit | -3,166,945 NOK |
| Total financial income | 471,473 NOK |
| Total financial expenses | 4,126 NOK |
| Net financial items | 467,347 NOK |
| Profit before tax | -2,699,598 NOK |
| Net result | -2,101,320 NOK |
| Total fixed assets | 607,989 NOK |
|---|---|
| Total current assets | 10,232,705 NOK |
| Total assets | 10,840,694 NOK |
| Paid-in equity | 3,155,714 NOK |
|---|---|
| Retained earnings | 7,674,957 NOK |
| Total equity | 10,830,671 NOK |
| Current liabilities | 10,024 NOK |
| Total debt | 10,024 NOK |
| Total equity and liabilities | 10,840,694 NOK |
Register of Company Accounts
Period 2024-01-01 to 2024-12-31. Currency NOK. Audited annual accounts.
| Total operating revenue | 10,612,217 NOK |
|---|---|
| Total operating expenses | 3,266,100 NOK |
| Operating profit | 7,346,117 NOK |
| Total financial income | 1,353,966 NOK |
| Total financial expenses | 1 NOK |
| Net financial items | 1,353,966 NOK |
| Profit before tax | 8,700,082 NOK |
| Net result | 7,076,990 NOK |
| Total fixed assets | 29,061 NOK |
|---|---|
| Total current assets | 13,432,055 NOK |
| Total assets | 13,461,116 NOK |
| Paid-in equity | 3,155,714 NOK |
|---|---|
| Retained earnings | 9,776,276 NOK |
| Total equity | 12,931,990 NOK |
| Current liabilities | 529,126 NOK |
| Long-term liabilities | 0 NOK |
| Total debt | 529,126 NOK |
| Total equity and liabilities | 13,461,116 NOK |
Register of Company Accounts
Period 2023-01-01 to 2023-12-31. Currency NOK. Audited annual accounts.
| Total operating revenue | 41,024 NOK |
|---|---|
| Total operating expenses | 3,817,934 NOK |
| Operating profit | -3,776,910 NOK |
| Total financial income | 1,318,201 NOK |
| Total financial expenses | 120,358 NOK |
| Net financial items | 1,197,843 NOK |
| Profit before tax | -2,579,067 NOK |
| Net result | -1,265,325 NOK |
| Total fixed assets | 1,385,062 NOK |
|---|---|
| Total current assets | 35,097,871 NOK |
| Total assets | 36,482,933 NOK |
| Paid-in equity | 3,155,714 NOK |
|---|---|
| Retained earnings | 22,699,286 NOK |
| Total equity | 25,855,000 NOK |
| Current liabilities | 10,627,933 NOK |
| Long-term liabilities | 0 NOK |
| Total debt | 10,627,933 NOK |
| Total equity and liabilities | 36,482,933 NOK |
Source: Register of Company Accounts, Brønnøysund Register Centre. Figures are shown as submitted, and historical years are never overwritten by newer submissions.
Calculated by us
| Key figures | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue growthChange in total operating revenue from the previous fiscal year. | – | 25,768.3 % | – |
| Operating marginOperating profit divided by total operating revenue. | – | 69.2 % | -9,206.6 % |
| Profit marginOrdinary profit before tax divided by total operating revenue. | – | 82 % | -6,286.7 % |
| Equity ratioTotal equity divided by total assets. | 99.9 % | 96.1 % | 70.9 % |
| Current ratioTotal current assets divided by total current liabilities. | 1,020.82 | 25.39 | 3.3 |
| Debt ratioTotal liabilities divided by total equity. | 0 | 0.04 | 0.41 |
| Return on assetsOrdinary profit before tax plus financial expenses, divided by total assets. | -24.9 % | 64.6 % | -6.7 % |
| Return on equityNet profit divided by total equity. | -19.4 % | 54.7 % | -4.9 % |
About the calculation
The key figures are calculated by us (formula version v1) from public accounts in the Register of Company Accounts. A figure is only calculated when all input values exist and the denominator is not zero. The figures are not a credit assessment.
Registry data
Source: The Brønnøysund Register Centre. We only show name and role as published by the register – never date of birth or private address.
Structure
Overview
SALMO PHARMA AS
SANDNESSJØEN
Registry data
| Name | Org. no. | Place | Employees |
|---|---|---|---|
| SALMO PHARMA ASResearch and experimental development on natural sciences and engineering | 923 198 733 | SANDNESSJØEN | – |
Registry data
Retrieved from the Brønnøysund Register Centre's official change log. Each line shows what changed, the previous value, the new value and when the change happened.
22 October 2026 at 09:30
Forretningsadresse
Before: Dønnaveien 496
After: Uraveien 32
22 October 2026 at 09:30
Postnummer
Before: 8820
After: 8802
22 October 2026 at 09:30
Poststed
Before: DØNNA
After: SANDNESSJØEN
22 October 2026 at 09:30
Kommune
Before: DØNNA
After: ALSTAHAUG
This has not been registered yet. We never show made-up information.
Services and products
The company has not added any services yet.
Public approvals
Not in the Norwegian Building Authority's central approval register.
Public contracts
No notices found in TED where the company is a supplier or contracting authority.
Documents
Certificates of registration and other documents require a separate agreement with a document provider.
Transparency
Company information
Brønnøysund Register Centre · Public register
Last retrieved 22 November 2026 at 08:55
Open official sourceRoles
Brønnøysund Register Centre · Public register
Last retrieved 22 November 2026 at 08:55
Open official sourceAccounts and key figures
Register of Company Accounts · Public register
Last retrieved 22 November 2026 at 08:55
Open official sourceAddress (verified)
Norwegian Mapping Authority – Geonorge address API · Public register
Last retrieved 22 November 2026 at 08:55
Open official sourceCentral approval
Norwegian Building Authority (DiBK) · No approval found
Last retrieved 22 November 2026 at 08:55
Open official sourceIndustry standard (SN2007)
Statistics Norway – KLASS · Official standard
Last retrieved 22 November 2026 at 08:55
Open official sourcePublic registry data is updated periodically and cannot be changed by the company. Calculated figures are marked “Calculated by us”.
Report an errorSource
Public registry fields on this page come from the Central Coordinating Register and cannot be changed by the company. Self-reported content is marked separately.
Read about the data sourcesTalk to Proffi
Leave your contact details and an adviser will explain how segmentation, company profiles and supplier search can support your business.